Systemic Redesign and Demonstration for Early Detection, Evaluation and Management of Chronic Kidney Disease in Shanghai

Overview

Based on clinical evidence based medicine and organizational management model, investigators redesign the prevention and treatment of chronic kidney disease of public health system in Shanghai China. The investigators hope to find early chronic kidney disease, prevention and clinical intervention of orderly combination. The advantages of this system were confirmed by comparing the prevalence rate, awareness rate and treatment rate before and after the completion of the system.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 31, 2017

Detailed Description

The whole study mainly includes the following parts:

1. Establishment of a database of patients with kidney disease, and training data entry specialist in every center.

2. Conduct propaganda of kidney disease knowledge, training professional doctors in center hospital and community hospital.

3. Search for high-risk patients, and screening for patients with kidney disease from community residents in community hospital.

4. Establishment of a standardized and orderly patient referral process from community hospital to center hospital or three level of first-class hospital.

Arms, Groups and Cohorts

  • chronic kidney disease patients group
    • These patients were screened from 2000000 of the population. The investigator will compare the prevalence rate, awareness rate and treatment rate before and after the completion of the system. The degree of decreased glomerular filtration rate is also an important evaluation index.

Clinical Trial Outcome Measures

Primary Measures

  • prevalence rate of chronic kidney disease
    • Time Frame: baseline and 12 months, an average of 3 years
    • Change in prevalence rate of chronic kidney disease in shanghai from baseline to 3 years.
  • awareness rate of chronic kidney disease
    • Time Frame: baseline and 12 months, an average of 3 years
    • Change in awareness rate of chronic kidney disease in shanghai from baseline to 3 years.
  • treatment rate of chronic kidney disease
    • Time Frame: baseline and 12 months, an average of 3 years
    • Change in using standardized and orderly patient referral process from community hospital to center hospital or three level of first-class hospital. in shanghai from baseline to 3 years.
  • The degree of decreased glomerular filtration rate in chronic kidney patients
    • Time Frame: through study completion, an average of 3 years
    • The degree of decreased glomerular filtration rate in chronic kidney patients, compared with healthy people and reported level in the literatures

Participating in This Clinical Trial

Inclusion Criteria

  • Over 18 years of age.
  • Signed informed consent

Exclusion Criteria

  • Refused to accept the blood and urine test

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Shanghai Changzheng Hospital
  • Collaborator
    • Shanghai Municipal Commission of Health and Family Planning
  • Provider of Information About this Clinical Study
    • Principal Investigator: Changlin Mei, Professor, Director of kidney Institute of the people’s Liberation Army – Shanghai Changzheng Hospital
  • Overall Official(s)
    • Changlin Mei, Master, Principal Investigator, Shanghai Changzheng Hospital
  • Overall Contact(s)
    • xiao Qin, Master, +8615800493668, sunnyqinxiao@163.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.